Natural killer (NK) cells contribute to immune responses to cancer 1,2 and viruses 3 . Unlike the receptors on lymphocytes of the adaptive immune system, such as B cells and T cells, the receptor repertoire of NK cells is independent of somatic rearrangement. Instead, their specificity for target cells results from the complex expression patterns of a large array of both activating and inhibitory receptors, many of which interact with major histocompatibility complex (MHC) class I molecules. The binding of MHC class I molecules by inhibitory receptors of the Ly49 and killer cell immunoglobulin-like receptor families blocks the activation of NK cells 4, 5 . The relevance of such interactions was demonstrated in a setting in which the absence of MHC class I rendered tumors more susceptible to control by NK cells 6 . That led to the development of the 'missing-self ' hypothesis 7 , which was subsequently supported by the observation that H-2D d protects tumor cells from the cytotoxicity of NK cells 4 . A recognition system for the missing-self hypothesis was elucidated when the inhibitory receptor Ly49A was specifically shown to directly recognize MHC class I molecules 4, 8 . In addition to suggesting a mechanism for the 'preferential' targeting by NK cells of tumors with low expression of MHC class I, such data also provide a basis for the mechanism by which NK cells develop tolerance to self.
Natural killer (NK) cells contribute to immune responses to cancer 1, 2 and viruses 3 . Unlike the receptors on lymphocytes of the adaptive immune system, such as B cells and T cells, the receptor repertoire of NK cells is independent of somatic rearrangement. Instead, their specificity for target cells results from the complex expression patterns of a large array of both activating and inhibitory receptors, many of which interact with major histocompatibility complex (MHC) class I molecules. The binding of MHC class I molecules by inhibitory receptors of the Ly49 and killer cell immunoglobulin-like receptor families blocks the activation of NK cells 4, 5 . The relevance of such interactions was demonstrated in a setting in which the absence of MHC class I rendered tumors more susceptible to control by NK cells 6 . That led to the development of the 'missing-self ' hypothesis 7 , which was subsequently supported by the observation that H-2D d protects tumor cells from the cytotoxicity of NK cells 4 . A recognition system for the missing-self hypothesis was elucidated when the inhibitory receptor Ly49A was specifically shown to directly recognize MHC class I molecules 4, 8 . In addition to suggesting a mechanism for the 'preferential' targeting by NK cells of tumors with low expression of MHC class I, such data also provide a basis for the mechanism by which NK cells develop tolerance to self.
Principal among the early models of tolerance was the 'at-least-one' hypothesis, which suggested that each NK cell expresses an inhibitory receptor specific for self MHC 9, 10 . However, many inhibitory receptors on mouse NK cells do not recognize syngeneic MHC class I molecules 11 , and some populations of NK cells lack inhibitory receptors that recognize self H-2D and H-2K MHC class I molecules 12 . Recognition of MHC class I is critical for the acquisition of full effector function, as NK cells from MHC class I-deficient mice have lower cytotoxicity and cytokine production 13 . Given those discoveries, many mechanisms of NK cell tolerance have been proposed 14 , but much attention has been focused on the role of 'licensing' . During this process, inhibitory receptors are proposed to recognize a self MHC class I molecule and license the cells to acquire cytotoxic potential and cytokine-producing ability 15 .
MHC class I-specific receptors from many different families regulate NK cell responses 16 . Inhibitory members of the Ly49 family have been shown to recognize specific allotypes of classical MHC class I molecules, whereas the highly conserved CD94-NKG2 receptors recognize the nonclassical molecules Qa-1 b in mice 17, 18 and HLA-E in humans 19, 20 . However, little is known of the ability of other nonclassical MHC class I molecules to regulate NK cell responses. H2-M3 is an MHC class Ib molecule encoded by a gene located at the telomeric end of the H2 region 21 . Although most cells retain H2-M3 in the endoplasmic reticulum, it is constitutively expressed on B cells 22 . H2-M3 1 1 7 2 VOLUME 13 NUMBER 12 DECEMBER 2012 nature immunology A r t i c l e s has a specialized role in the presentation of N-formylated peptides of bacterial or mitochondrial origin 23, 24 , of which the best characterized are the Listeria monocytogenes peptide LemA (fMIGWII) 25 and the mitochondrial natural ligand peptide derived from the amino terminus of the NADH dehydrogenase subunit ND1 (fMFFINIL) 26 . Complexes of peptide and H2-M3 can be recognized by a specialized population of CD8 + T cells that are important for immunity to infection with certain bacteria 27 . However, studies have also demonstrated that lymphocytes from H2-M3-deficient (H2-M3 tm1Crw ) mice have an impaired ability to kill NK cell-sensitive target cells such as YAC-1 cells 28 , which suggests that H2-M3 may regulate NK cell responses.
Here we demonstrate that peptide-H2-M3 is a ligand for the NK cell inhibitory receptor Ly49A. Given that no definitive ligand of Ly49A has been recognized on the H-2 b background, we investigated the role of H2-M3 in the responses of Ly49A + NK cells. The absence of H2-M3 resulted in NK cell hyporesponsiveness, missing-self rejection and a greater tumor burden in a Ly49A-dependent way. Our results demonstrate that the ligands for the Ly49 family of molecules may exist outside classical MHC class I and suggest that reexamination of the at-least-one hypothesis is needed.
RESULTS

H2-M3 tetramers bind to C57BL/6 Ly49A
Given the diminished killing ability of NK cells from H2-M3-deficient mice 28 , we sought to determine the relationship between H2-M3 and other ligands of well-characterized receptors on NK cells. Sequence alignment identified homology of the α1 and α2 domains of H2-M3 (National Center for Biotechnology Information (NCBI) accession code, NP_038847.1) with H-2D d (NCBI accession code, AAA39581) and H-2D b (NCBI accession code, NP_034510; Fig. 1a) . As H-2D d and H-2D b may be ligands for Ly49A 4, 8, 11, [29] [30] [31] [32] [33] , we assessed the ability of H2-M3 tetramers loaded with fMIGWII 25 or fMFFINIL 26 to stain Chinese hamster ovary cells transfected to express Ly49A, Ly49D or Ly49G2 molecules 11, 34 . Cells expressing Ly49A bound H2-M3 tetramers, but cells expressing Ly49D or Ly49G2 did not (Fig. 1b) . As expected 4, 8, 11 , an H-2D d tetramer loaded with the peptide motif AGPARAAAL bound cells expressing Ly49A 8 but not those expressing Ly49D or Ly49G2 (Fig. 1b) . There was also no binding of a HLA-B8 tetramer loaded with an immunodominant epitope of Epstein-Barr virus 35 to any of the Ly49-expressing cells (Fig. 1b) , which further demonstrated the specificity of the interaction. Moreover, the binding of H2-M3 tetramer to Ly49A-expressing cells was blocked by pretreatment with the Ly49A-specific monoclonal antibody YE1/48 (Fig. 1c) . These data demonstrated that Ly49A was able to recognize the nonclassical MHC class I molecule H2-M3.
H2-M3 and H-2D d bind with similar affinity to Ly49A
To provide further evidence that H2-M3 binds Ly49A, we assessed by surface plasmon resonance the interactions between recombinant Ly49A and H2-M3 refolded with fMIGWII or fMFFINIL, H-2K b refolded with the ovalbumin peptide SIINFEKL, or H-2D d refolded with AGPARAAAL. The data were fitted to a Langmuir 1:1 model, with χ 2 values (≤5) and residuals indicating a good data fit (Fig. 2) . H2-M3 in complex with fMIGWII (Fig. 2a) or fMFFINIL (Fig. 2b) bound to Ly49A with an affinity (2.75 ± 0.071 µM (fMIGWII) or 4.06 ± 0.33 µM (fMFFINIL)) similar to that of the binding of Ly49A to H-2D d . The affinity of AGPARAAAL-loaded H-2D d for Ly49A (2.05 ± 0.07 µM; Fig. 2c ) was similar to published values 36 . In contrast, we observed no interaction between Ly49A and SIINFEKL-loaded H-2K b (Fig. 2d) , as has been reported before 11, 29 . These results demonstrated the specificity of these interactions.
Normal NK cells and MHC class I in H2-M3-deficient mice
Given the diminished ability of lymphocytes from H2-M3-deficient mice to kill YAC-1 cells 28 and the reported observation that certain receptors on NK cells may regulate the development of NK cells 37 , we next determined whether the absence of H2-M3 affected the development of NK cells. We used monoclonal antibodies to CD27 and CD11b, to CD43 and CD11b, and to NK1.1 and CD122 to identify NK cells and their maturation phenotypes 38, 39 , and thereby determined that the maturation and total number of NK cells were unaffected in H2-M3-deficient mice (Fig. 3a,b) . All known members of the Ly49 and NKG2 families were expressed normally; however, H2-M3-deficient mice had a slight but significantly greater frequency of NK cells that expressed the NK cell receptor DNAM-1 ( Fig. 3b and Table 1 ).
To confirm that the absence of H2-M3 did not alter the expression of classical MHC class I molecules, we assessed the expression of H-2K b and H-2D b in the spleen and bone marrow. Expression of these classical H-2 molecules was unaffected by the absence of H2-M3 (Fig. 3c) . In line with published experiments 22 , H2-M3 was constitutively expressed on B cells in the spleen and bone marrow (which represent approximately 50% of all leukocytes in these organs; Fig. 3c ). Thus, whereas H2-M3 was required for the lymphocyte-mediated killing of YAC-1 cells, its absence resulted in little or no difference in the development of NK cells.
H2-M3 is required for suppression of tumors by NK cells
Given that peptide-H2-M3 was recognized by Ly49A, we next defined the role of H2-M3 during melanoma metastasis and fibrosarcoma development, both models in which NK cell-mediated control is critical. After intravenous injection of a range of doses of B16-F10 mouse melanoma tumor cells, H2-M3-deficient mice had significantly more lung metastases than did wild-type control mice (Fig. 4a) A r t i c l e s load (Fig. 4a) . These results demonstrated a dose-dependent defect in NK cell-mediated resistance to melanoma lung metastases in the absence of H2-M3.
In concert with the results obtained for experimental B16-F10 lung metastases, we also observed a carcinogen dose-dependent effect of host H2-M3 on the penetrance of fibrosarcoma induced by the carcinogen MCA (Fig. 4b) . A significantly greater proportion of H2-M3-deficient mice than wild-type mice developed fibrosarcoma at a dose of 25 µg MCA, whereas despite the presence of a similar trend, we observed no statistical difference between wild-type and H2-M3-deficient mice challenged with higher doses of MCA (100 or 400 µg; Fig. 4b) . The difference between wild-type and H2-M3-deficient mice in terms of the carcinogenic effect of MCA was completely abrogated in the absence of NK cells achieved with a depleting antibody to the ganglioside asialo-GM1 (anti-asialo-GM1), which resulted in a similar but greater tumor penetrance in both strains (Fig. 4b) .
In an independent experiment, heterozygous H2-M3 +/− mice had a sensitivity to MCA similar to that of H2-M3 +/+ mice, with both groups having a greater proportion of mice that remained tumor free than did groups of mice that completely lacked H2-M3 ( Supplementary  Fig. 1 ). Thus, in two models (one of experimental carcinogenesis and one of newly developed carcinogenesis) in which it was critical that NK cells provide protection of the host from tumors, host H2-M3 was required for optimal NK cell activity.
H2-M3 licenses Ly49A + NK cells and regulates tumor control Given our finding of diminished NK cell activity in H2-M3-deficient mice, we assessed the possibility that H2-M3-dependent licensing may be required for NK cells to obtain full effector function. To confirm this hypothesis, we used a well-established licensing assay designed to detect differences in the acquisition of the production of interferon-γ (IFN-γ) by NK cells 15, 40 . We excluded NK cells expressing the known inhibitory receptors Ly49C/I, Ly49G2 and NKG2ACE (those expressing Ly49F/H were also excluded as a result of antibody cross-reactivity) and analyzed cytokine production by the Ly49A + population (which included Ly49D + cells and NKG2D + cells) after crosslinkage with the PK136 monoclonal antibody to NK1.1. IFN-γ production in the Ly49A + NK cell pool was significantly lower in H2-M3-deficient mice than in wild-type mice (Fig. 5a,b) . The Ly49C/I + Ly49G2 − Ly49A − NKG2ACE − and Ly49C/ I − Ly49G + Ly49A − NKG2ACE − populations were licensed equivalently in wild-type and H2-M3-deficient mice (Fig. 5b) , which demonstrated the specificity of the Ly49A + NK cell-H2-M3 axis.
To determine whether the diminished licensing of Ly49A + NK cells in H2-M3-deficient mice had any pathophysiological consequences, we assessed the ability of wild-type and H2-M3-deficient mice to control B16-F10 tumors after depletion of Ly49A + NK cells. We treated mice with the antibody YE1/32, which results in depletion specifically of the Ly49A + subset 41 , before injecting the mice with B16-F10 tumor cells. Depletion of this subset in wild-type mice resulted in significantly more lung metastases (Fig. 5c) . Consistent with the results presented above (Fig. 4) , H2-M3-deficient mice had significantly more lung metastases, a result that was not altered after depletion of Ly49A + NK cells (Fig. 5c) . Thus, H2-M3 provided a licensing signal to Ly49A + NK cells, which resulted in the generation of effector function. 
A r t i c l e s
H2-M3 is a missing-self determinant
According to the missing-self hypothesis, the absence of MHC class I on naive hematopoietic cells should result in their rejection. Indeed, the transfer of resting lymphocytes from β 2 -microglobulin-deficient (B2m tm1Unc ) mice into wild-type recipient mice results in their rejection in an NK cell-dependent manner 42 . We therefore sought to determine whether H2-M3 could act as a missing-self determinant by transferring bone marrow cells (Fig. 3 ) from wild-type and H2-M3-deficient mice into wild-type recipients. We labeled freshly isolated bone marrow cells with the cytosolic dyes CFSE or CellTrace Violet, mixed the cells at a ratio of 1:1 and injected the mixture into wild-type mice. Some recipients received a mixture (1:1) of wild-type cells labeled with CFSE or Cell Trace Violet as a control. Cell Trace Violet-labeled bone marrow cells from H2-M3-deficient mice transferred at a ratio of 1:1 with CFSE-labeled wild-type cells underwent significantly more rejection than did cells in mice that received only wild-type cells (Fig. 6) . This rejection was dependent on Ly49A and NK cells, as treatment with depleting antibodies to Ly49A or NK1.1 abrogated the rejection and resulted in retention similar to that observed in wild-type mice given wild-type cells alone (Fig. 6) . Given that the bone marrow constitutively expressed H2-M3, the observed enhanced NK cell-dependent rejection of H2-M3-deficient cells was consistent with models of missing self 42 .
DISCUSSION
The relevance of Ly49A to NK cell responses has received much attention since its identification over 20 years ago [43] [44] [45] . Here we found that H2-M3, which is highly conserved across mouse strains and is expressed in mice with H-2 b haplotypes, such as C57BL/6 mice, interacted with Ly49A. Moreover, H2-M3 was able to license NK cells and regulate rejection in a Ly49A-dependent manner, results consistent with the present theories of NK cell 'education' 14 and models of missing self 42 . Although H2-M3 contributed to the licensing of Ly49A + NK cells, these cells are licensed more weakly in H-2 b mice than in H-2 d mice 46 . Our data have shown that Ly49A had a similar affinity for H2-M3 and H-2D d , which suggests that other factors in addition to the affinity of The at-least-one model proposed that every mature NK cell expresses an inhibitory receptor specific for a self MHC class I molecule 9, 10 . Subsequent experiments have demonstrated that subsets of NK cells exist that achieve self-tolerance without expressing self MHC class I-reactive receptors 12 . Furthermore, the licensing hypothesis has provided important mechanistic data on NK cell tolerance 14, 48 . Such observations have led to the suggestion that the at-least-one model is not correct. However, similar to what has been noted for the education of CD8 + T cells, it is possible that NK cell self-tolerance is achieved through multiple interactions. Given that Ly49A + NK cells are weakly licensed on the H-2 b background but have a self ligand, this suggests that the at-least-one model may be valid for this subset of cells. Our data have shown that Ly49 molecules may be able to recognize nonclassical MHC class I, which would provide a source of ligands for those inhibitory receptors that do not bind classical MHC class I. Identifying and quantifying such interactions would benefit the study of NK cell education.
METHODS
Methods and any associated references are available in the online version of the paper. For Ly49-expressing cells, cells were plated for 2 d onto Corning suspension dishes at a density of 2 × 10 5 cells per ml and were removed from the dishes with 50 mM EDTA and washed twice in PBS, then nonspecific receptors were blocked with mAb 2.4G2. Cells were then stained with the antibodies to Ly49 described above or tetramers, then were fixed in 2% paraformaldehyde and washed, and 2 × 10 4 events were collected on an LSR II (BD Biosciences).
Cloning and expression of recombinant proteins. RNA from C57BL/6 mice was reverse-transcribed and used for the amplification of a cDNA fragment encoding the entire extracellular domain of Ly49A (residues 67-262) with the following primers (5′ to 3′): GGCCGGATCCAAAATTTTTCAGTATG and CCGCTAGCTCAATGAGGGAATTTATC. The construct was then cloned into the pHLsec vector for mammalian expression, which contains secretion tags as well as an amino-terminal six-histidine tag for purification and a BirA signal peptide for biotinylation. The Ly49A extracellular domain was expressed from transiently transfected human embryonic kidney 293T cells, and the secreted protein was collected and dialyzed against a buffer of 10 mM Tris, pH 8.0, and 500 mM NaCl, followed by purification on nickel-affinity resin and elution from the resin through the use of a buffer of 10 mM Tris, pH 8.0, 500 mM NaCl and 500 mM imidazole. The protein was purified by gelfiltration chromatography with an S200 16/60 column (GE Healthcare).
After reverse transcription of RNA prepared from C57BL/6 splenocytes, cDNA encoding residues 1-274 of H2-M3 was generated by PCR and cloned into a pET-30 based vector that allowed inframe fusion of a substrate peptide for the enzyme BirA. The H2-M3 heavy chain and mouse β 2 -microglobulin were expressed separately in Escherichia coli, purified from inclusion bodies and refolded in the presence of fMIGWII) or fMFFINIL and purified essentially as described 49 . The cloning and expression of H-2D d , H-2D b and H-2K b has been described 11 .
Surface plasmon resonance. A ProteOn XPR36 protein-interaction array system (Bio-Rad) was used for surface plasmon resonance as described 50 .
Streptavidin was coupled to a GLC Sensor Chip (Bio-Rad) by amine coupling (~500 response units), and biotinylated Ly49A produced from 293T cells was captured on the surface (~80 response units). An empty flow cell containing streptavidin alone served as a control surface. Serial dilutions (16-1 µM) of monomeric fMIGWII-H2-M3, fMFFINIL-H2-M3, AGPARAAAL-H-2D d or SIINFEKL-H-2K b were simultaneously injected over test and control surfaces at a rate of 30 µl/min for 240 s. After subtraction of those results from results obtained with the control flow cell, kinetic interactions were analyzed with ProteOn Manager software version 3.0.1. All interactions were tested minimally in duplicate.
In vivo tumor assays. For the B16-F10 model, single-cell suspensions of B16-F10 were prepared in PBS, and 1 × 10 4 to 2 × 10 5 cells were injected intravenously into the tail vein. Lungs were collected on day 14 and fixed in Bouin's solution, and tumor nodules were counted with the aid of a dissection microscope. For blockade or depletion studies, mice were treated intraperitoneally with control immunoglobulin (2A3; prepared in-house), anti-asialo-GM1 (Wako Pure Chemicals), anti-CD8β (53.5.8; prepared in-house) or anti-NK1.1 (PK136; prepared in-house) at a dose of 100 µg on days -1, 0 and 7, or with anti-Ly49A (YE1/32; provided by B. Murphy) at a dose of 300 µg on days -2 and 5.
For the MCA model, groups of 10-25 male wild-type or H2-M3-deficient mice (or groups of 14-25 male wild-type mice, mice heterozygous for H2-M3 deficiency and or H2-M3-deficient mice for F 1 studies) were inoculated subcutaneously in the hind flank with 25, 100 or 400 µg MCA (3-methylcholanthrene; Sigma-Aldrich) in 0.1 ml corn oil. Some mice received control immunoglobulin or were depleted of NK cells weekly (with antiasialo-GM1) from the time of MCA inoculation to day 42. The development of fibrosarcomas was monitored weekly over the course of 300 d. Tumors over 3 mm in diameter that demonstrated progressive growth were considered positive. Measurements were made with a caliper square as the product of two perpendicular diameters (cm 2 ).
Licensing assays. Licensing assays were done as described 40, 46 .
Missing-self rejection. Missing-self assays were done as described 42 with minor modifications. For depletion studies, mice were treated intraperitoneally with control immunoglobulin (2A3) or anti-NK1.1 (PK136) at a dose of 100 µg on days -1 and 0 or with anti-Ly49A (YE1/32) at a dose of 300 µg on days -2 and 0.
Statistical analysis. The nonparametric, two-tailed Mann-Whitney U-test was used to determine the statistical significance of data sets not involving survival. Survival data sets were analyzed with the log-rank (Mantel-Cox) test. P values of less than 0.05 were considered significant. 
